Topics
Editorially Independent Content, Supported With Advertising From Astellas
September 2026 Insert | GA Fundamentals
Defining Early Geographic Atrophy Requires More Than Lesion Size
Sean D. Adrean, MD, FAAO
July/August 2026 Supplement | GA Fundamentals
The Role of Multimodal Imaging in Geographic Atrophy
How imaging modalities support diagnosis, monitoring, treatment discussions, and patient education.
Durga S. Borkar, MD, MMCi
May/June 2026 Insert | GA Fundamentals
Understanding Fast Progression in Geographic Atrophy
Risk stratification, imaging, and patient counseling all support earlier recognition and management of GA.
Carl J. Danzig, MD, FASRS
Gaining Patients’ Buy-in With Geographic Atrophy Treatment: The Journey From Diagnosis to Long-term Adherence
Setting realistic expectations for treatment with empathy, education, and reinforcement supports long-term adherence.
David S. Chin Yee, MD
March 2026 Insert | GA Fundamentals
Early Bilateral Complement Inhibition in Extrafoveal Geographic Atrophy
Daniel Su, MD, and Matthew C. Johnson, MD
January 2026 Insert | GA Fundamentals
Identifying Early Disease and Geographic Atrophy Risk Factors in AMD
Functional symptoms, imaging biomarkers, and early referral support timely detection and management of GA.
Adrienne W. Scott, MD, FASRS
November/December 2025 Insert | GA Fundamentals
Setting Expectations for Geographic Atrophy Treatment
From early- to late-stage disease, tailored conversations emphasize preservation, proactive care, and supportive strategies.
Sonia Mehta, MD
October 2025 Insert | GA Fundamentals
Treating Geographic Atrophy in Real-world Practice: A Case Example
July/August 2025 Insert | GA Fundamentals
Bridging the Visual Disconnect in Geographic Atrophy
Educating asymptomatic and early-stage patients on risks drives adherence to therapy.
Caesar K. Luo, MD, FASRS
March 2025 Insert | GA Fundamentals
Navigating a GA Patient’s Journey Through Clinic
Use of imaging and relevant educational supplements can help cut down on extended chair time.
Esther L. Kim, MD
January/February 2025 Insert | GA Fundamentals
Evolving the Treatment Paradigm in Geographic Atrophy: Considerations for Early Initiation of Therapy
Complement inhibitors have transformed the landscape, changing how patients with intermediate AMD are followed in the clinic.
Chirag D. Jhaveri, MD
November/December 2024 Insert | GA Fundamentals
Broadening the Scope of Complement Inhibitor Treatment
Balancing early intervention and long-term adherence, retina specialists leverage imaging and patient education to optimize geographic atrophy treatment with complement inhibitors.
May/June 2024 Insert | GA Fundamentals
How Do You Engage With Your Referral Network?
A collaborative approach between retina specialists and referring providers is key to diagnosing and monitoring patients with geographic atrophy.
Priya Sharma Vakharia, MD
April 2024 Insert | GA Fundamentals
Geographic Atrophy: Guiding the Conversation With Patients
Helping patients with geographic atrophy understand their disease through analogies and clear communication can empower them to make informed treatment decisions.
October 2, 2026
Euretina Data Highlight Real-World Vabysmo Outcomes in Wet AMD, DME, and RVO
October 1, 2026
Atsena Reports 18-Month ATSN-201 Results in X-Linked Retinoschisis
Galimedix Highlights Patient-Tailored Microperimetry in Phase 2 eDREAM Geographic Atrophy Study
Nanoscope’s Mogenry Granted Priority Review in Japan for Inherited Retinal Dystrophies
Free Print Subscription
Email Newsletter
Conference Calendar